Improving T cell recovery after blood stem cell transplants
Promoting T cell reconstitution after hematopoietic cell transplantation
This study is looking at ways to help your immune system recover better after a stem cell transplant by finding ways to repair the thymus, the organ that makes T cells, which are important for fighting infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11001837 on NIH RePORTER |
What this research studies
This research focuses on enhancing the recovery of T cells, which are crucial for immune function, following hematopoietic cell transplantation (HSCT). It investigates the thymus, the organ responsible for T cell generation, and how it can be repaired after damage caused by cancer treatments. The study aims to identify therapies that stimulate the natural regenerative processes of the thymus, particularly through the roles of specific signaling molecules and cell death pathways. By understanding these mechanisms, the research seeks to improve patient outcomes post-transplant.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who are undergoing or have recently undergone hematopoietic cell transplantation.
Not a fit: Patients who have not received HSCT or those with conditions unrelated to T cell recovery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immune recovery for patients undergoing blood stem cell transplants, reducing the risk of infections and complications.
How similar studies have performed: Previous research has shown promise in enhancing thymic regeneration and T cell recovery, indicating that this approach has potential for success.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Dudakov, Jarrod — Fred Hutchinson Cancer Center
- Study coordinator: Dudakov, Jarrod
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.